At meeting held on 07 January 2021
The Board of Glaxosmithkline Pharmaceuticals at its meeting held on 07 January 2021 has approved the following change in directorate -Resignation of Raju Krishnaswamy as a Director of the Company with effect from 27 January 2021.
Appointment of Mark Dawson as a Non - Executive Director of the company with effect from 28 January 2021.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
